🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Genomic landscape of distant mets endometrial ca sciencedirect.com/science/articl… Distant mets are mostly CNH/TP53abn or CNL/NSMP molec subtype & harbor higher levels of chromosomal instability than primary ECs. Clinically actionable alterations are less common in mets vs. primary ECs

Hoping to see you all there! #IJGCclub #endometrialcancer #LVSI IJGC IJGC Fellows ESGO IGCS Houston Methodist Memorial Sloan Kettering Cancer Center

At ABOG Gyn Onc oral board exam, Dallas TX. The Gold Standard in Gyn Onc certification. Thank you Dr. Kim for outstanding organization. Team Ovary, Memorial Sloan Kettering Cancer Center MSKCC Team Uterus IGCS Kenneth H Kim

April #LeadArticle Effect of substantial #LVSI on location of first disease recurrence in surgical stage I endometrioid #endometrialadenocarcinoma 🔗 bit.ly/3EaK6A4 ✅ Focal and substantial #LVSI was associated with a 3-fold increased ⬆️ risk of cumulative incidence

We were so fortunate to have a fantastic visit from Susana Banerjee discussing her incredible groundbreaking work The Royal Marsden NHS Foundation Trust. We are truly inspired by her career and commitment to innovation and excellent patient care. Team Ovary, Memorial Sloan Kettering Cancer Center MSKCC Team Uterus

Amazing talk and then dinner with the amazing and brilliant Dr. Banerjee from the Royal Marsden! ⁦Team Ovary, Memorial Sloan Kettering Cancer Center⁩ ⁦MSKCC Team Uterus⁩

April 2025 IJGC Journal Club: Effect of substantial LVSI on location of first disease recurrence in surgical stage I endometrioid endometrial adenocarcinoma youtu.be/_ZyMkKWigJ0?si… via YouTube

Multi-center, international endometrial cancer consortium highlights sciencedirect.com/science/articl…. Thanks to our colleagues at Mayo Clinic for organizing this event.

Take a look at this innovative manuscript from Aaron Praiss MD Dmitriy Zamarin MD PhD Lea A. Moukarzel Tiffany Sia MD Ryan Kahn, MD, MHS and team evaluating tumor stress response during cytoreductive surgery for #ovarian cancer. Team Ovary, Memorial Sloan Kettering Cancer Center MSKCC Team Uterus pubmed.ncbi.nlm.nih.gov/40256326/

Congratulations to the MSK-IMPACT team at MSK for receiving the American Association for Cancer Research (AACR) Team Science Award. The team, led by Michael Berger, David B. Solit, MD, and Marc Ladanyi, is recognized for its pivotal advances in clinical genomic sequencing that have transformed

Molecular subtypes & genomic landscape of undifferentiated dedifferentiated endometrial ca pubmed.ncbi.nlm.nih.gov/40288099/ Undiff/dediff endometrial ca are heterogeneous; the majority are MSI-high/MMRd, may have therapeutic implications.MSKCC Team Uterus Team Ovary, Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center

Genomic Analysis of Uterine Serous Ca Arising From Endom Hyperplasia pubmed.ncbi.nlm.nih.gov/40298247/ USC & co-occurring hyperplasia were clonally related, TP53 mutations in both components. Suggests an alternative origin of tumorigenesis.MSKCC Team Uterus Team Ovary, Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center

Artificial intelligence in the diagnosis & management of gynecologic cancer pubmed.ncbi.nlm.nih.gov/40277295/ AI presents significant potential to improve outcomes in Gyn oncology, particularly in bridging healthcare gaps in resource-limited settings.Team Ovary, Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center

Congrats to Sara Moufarrij and team for phenomenal work that may translate into new tx option for uterine cancer! We spent years refining our organoid protocol and the work is clearly paying off Nadeem R. Abu-Rustum @GynOncJnls Memorial Sloan Kettering Cancer Center MSKCC Team Uterus sciencedirect.com/science/articl…

🚨The FDA granted accelerated approval to avutometinib & defactinib for adults with KRAS-mutated recurrent low-grade serous #ovariancancer. Congrats to MSK's Rachel Grisham, Global Lead Principal Investigator of GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301! bit.ly/3ETZS2F

Most uterine carcinosarcomas have detectable TROP2 expression. In an innovative study by Sara Moufarrij and team, organoid models showed encouraging response to TROP2 targeted antibody drug conjugate sacituzumab govitecan. Team Ovary, Memorial Sloan Kettering Cancer Center MSKCC Team Uterus pubmed.ncbi.nlm.nih.gov/40344963/

We were so fortunate to have a fantastic discussion with world-renowned expert Dr. Pei Hui MD PhD regarding diagnosis and management of gestational trophoblastic neoplasia as part of our departmental lecture series program. Team Ovary, Memorial Sloan Kettering Cancer Center MSKCC Team Uterus

Important new study of prognostic implications of estrogen receptor (ER) expression in no specific molecular profile (NSMP) #endometrial cancer. ER+ was associated with better survival outcomes in the NSMP group. Amir Momeni MSKCC Team Uterus pubmed.ncbi.nlm.nih.gov/40414144/

Terrific first day in Nairobi Kenya working with colleagues from African Cancer Coalition to update NCCN Harmonized Sub-Saharan Africa guidelines. National Comprehensive Cancer Network (NCCN) MSKCC Team Uterus Team Ovary, Memorial Sloan Kettering Cancer Center American Cancer Society Memorial Sloan Kettering Cancer Center IGCS

Incredible work by Kenya National Hospital in Nairobi to improve oncology patient experience with Navigators, working with colleagues from African Cancer Coalition, ACS and NCCN. National Comprehensive Cancer Network (NCCN) MSKCC Team Uterus Team Ovary, Memorial Sloan Kettering Cancer Center American Cancer Society Memorial Sloan Kettering Cancer Center IGCS